Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors
Authors:
Top Cited Papers
Open Access
- 30 April 2024
- journal article
- review article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 150 (5) , 1-10
Abstract
Vascular endothelial growth factor A (VEGF-A), a highly conserved dimeric glycoprotein, is a key regulatory gene and a marker molecule of angiogenesis. The upregulation of VEGF-A facilitates the process of tumor vascularization, thereby fostering the initiation and progression of malignant neoplasms. Many genes can adjust the angiogenesis of tumors by changing the expression of VEGF-A. In addition, VEGF-A also exhibits immune regulatory properties, which directly or indirectly suppresses the antitumor activity of immune cells. The emergence of VEGF-A-targeted therapy alone or in rational combinations has revolutionized the treatment of various cancers. This review discusses how diverse mechanisms in various tumors regulate VEGF-A expression to promote tumor angiogenesis and the role of VEGF-A in tumor immune microenvironment. The application of drugs targeting VEGF-A in tumor therapy is also summarized including antibody molecule drugs and traditional Chinese medicine.Keywords
This publication has 114 references indexed in Scilit:
- The roles and limitations of bevacizumab in the treatment of ovarian cancerInternational Journal of Clinical Oncology, 2022
- LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC/STAT3/VEGFA pathwayGastric Cancer, 2022
- Long noncoding RNA TUG1 upregulates VEGFA to enhance malignant behaviors in stomach adenocarcinoma by sponging miR‐29c‐3pJournal of Clinical Laboratory Analysis, 2021
- Asiatic acid inhibits angiogenesis and vascular permeability through the VEGF/VEGFR2 signaling pathway to inhibit the growth and metastasis of breast cancer in micePhytotherapy Research, 2021
- GDF-15 Level Correlates with CMKLR1 and VEGF-A in Tumor-free Margin in Colorectal CancerCurrent Medical Science, 2021
- Alginic acid inhibits non-small cell lung cancer-induced angiogenesis via activating miR-506 expressionJournal of Natural Medicines, 2021
- Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patientsCancer Immunology, Immunotherapy, 2021
- Coenzyme Q10 in association with metabolism-related AMPK/PFKFB3 and angiogenic VEGF/VEGFR2 genes in breast cancer patientsMolecular Biology Reports, 2020
- Increased number of intratumoral IL-17+ cells, a harbinger of the adverse prognosis of triple-negative breast cancerBreast Cancer Research and Treatment, 2020
- A novel lncRNA‐LINC01116 regulates tumorigenesis of glioma by targeting VEGFAInternational Journal of Cancer, 2019